The Häagen-Dazs brand is helping to change the way ingredients are grown to better support bee populations by working hand-in-hand with its farmer suppliers. The internationally-recognized ice cream brand has installed one of the largest, privately funded pollinator habitats on the farmland of its almond supplier in California’s Central Valley. No stranger to helping the bees, the brand aims to impact additional ingredients used throughout its super-premium ice cream portfolio and positively influence sustainable agriculture practices.
The “Häagen-Dazs Loves Honey Bees” program launched in 2008, and today is expanding from research and educational funding to hands-on initiatives that will rejuvenate pollinator habitats to allow native bees to flourish. Located in Chowchilla, California, the habitat consists of six and a half miles of hedgerow and 11,000 native drought-tolerant shrubs and flowering plants, impacting 840 acres of farmland. In order to supply what pollinators need, the Häagen-Dazs brand worked with expert agronomists and the Xerces Society to maximize the impact of the habitat by choosing regional plants that are attractive to pollinators. Looking forward, the team will work to create custom habitats for more of its ingredient suppliers who depend on bees to pollinate their crops.
To view the multimedia release go to:
https://www.multivu.com/players/English/8075051-haagen-dazs-sustainable-agriculture-bees-pollinator-habitats/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
“Someone special at St. Jude would like to say hello,” this is what Guests at Chili’s® Grill & Bar Highland Springs restaurant heard after choosing to donate to St. Jude Children’s Research Hospital® during this year’s Create-A-Pepper campaign. It’s often difficult to connect how an add-on donation at the end of a meal or coloring a pepper while at Chili’s can have an impact on the kids at St. Jude, but over the past 15 years, each donation and pepper has added up to more than $64 million to support St. Jude’s mission of Finding cures. Saving children®.
This year, Chili’s is showing how a little action can create a big impact by continuing to connect those who care with those in need of care. ChiliHeads at Highland Springs in Beaumont, Calif. surprised everyday Guests with a special thank you for their donation to St. Jude. Guests came in expecting a normal dining experience and got something completely different. After a donation, Guests received a video call from a St. Jude survivor who personally shared their story and the difference each donation makes in ensuring that no family ever receives a bill.
To view the multimedia release go to:
https://www.multivu.com/players/English/8227251-chilis-st-jude-create-a-pepper/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr on receiving the 2015 Institut de France’s Grand Prix Scientifique in a Paris awards ceremony.
The Grand Prix is one of the largest prizes for scientific accomplishment and is considered the world’s most prestigious prize for cardiovascular research. The Institut’s board awarded Starr the Grand Prix in recognition of research that led to the world’s first successful artificial mitral valve implant in 1960. In the last 55 years, millions of patients around the world have benefitted from the emergence of the field of heart valve replacement and the many technological advances that followed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7536851-france-grand-prix-starr-edwards/
A new solar power system is installed in the United States every 1.6 minutes, according to the Solar Energy Industries Association (SEIA). With the number of residential solar installations expected to increase this year by 35 percent according to GTM Research, more consumers will have an opportunity to choose the best solar solution for their home, saving on electricity bills while generating clean energy. Offering a record-setting, proven solar power solution, SunPower reminds homeowners that better solar technology exists and is accessible today.
“Solar technology differs widely from brand to brand, so it’s important for consumers to consider that not all panels deliver the same amount of energy, look elegant on a roof, or are guaranteed to last as long as promised,” said Howard Wenger, SunPower president, business units. “SunPower® panels are the most efficient that homeowners can buy, and we stand behind them for a quarter century. We’re proud to hold the world-record title for efficiency.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7706151-sunpower-residential-solar-panel/
Popular tradition gives vinegar many healthful benefits, both through topical and internal use: it is antiseptic, antioxidant, purifying, soothing, protective, and toning.
This new interest motivated hair colouring pioneer Christophe Robin to study the cosmetic properties linked to vinegar, and research formulas inspired by traditional recipes to create a product that meets the current needs of both men and women.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7560651-christophe-robins-botanical-vinegars/
High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65964-ccfa-genetic-microbiome-discoveries-ibd-crohn-s-disease-ulcerative-colitis
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
Christina Nicols, senior vice president and director of strategic planning and research at Hager Sharp, was named the Washington Women in Public Relations’ (WWPR) 2015 Washington PR Woman of the Year Friday in a ceremony honoring top public relations executives and celebrating women in communications.
Nicols was one of three public relations professionals chosen as an honoree for the 26th annual award. The other finalists were Carrie Fox, president of C. Fox Communications, and Lisa Throckmorton, chief operations officer at SpeakerBox Communications. The three finalists represent women who have led some of the most influential communications campaigns in the District and across the country.
“This is a phenomenal honor and I am humbled to be surrounded by such exemplary leaders in the field who are dedicated to mentoring and supporting the next generation of public relations professionals,” said Nicols. “It is a special privilege to join the ranks of previous PR Woman of the Year recipients including Hager Sharp’s own cofounders Susan Hager and Marcia Sharp, as well as our CEO Jennifer Wayman and executive vice president Debra Silimeo.”
Nicols was presented the award by Silimeo, the 2010 PR Woman of the Year, at Friday’s luncheon.
To view the multimedia release go to:
http://www.multivu.com/players/English/7695751-2015-wwpr-woman-of-the-year-award/
CVS Health, the nation’s largest pharmacy innovation company, today launched an in-store fundraising campaign at CVS Pharmacy locations nationwide to benefit the American Lung Association’s LUNG FORCE initiative which aims to make lung cancer, the leading cancer killer of women in the United States, a public health priority.
Now through June 11, customers can donate $1, $3 or more at the register at 7,900 CVS Pharmacy locations and online at www.cvs.com/lung (all proceeds will support the initiative). CVS Health is the national presenting sponsor of LUNG FORCE, which is focused on raising awareness about lung cancer in women, and increasing research funding to save lives.
To view the multimedia release go to:
http://www.multivu.com/players/English/7817251-cvs-health-lung-force-fundraiser/
A whopping 80 percent of enterprises are investing today in AI, but one in three business leaders believe their company will need to invest more over the next 36 months to keep pace with competitors. At the same time, enterprises are anticipating significant barriers to adoption and are looking to strategize against those issues by creating a new C-suite position, the Chief AI Officer (CAIO), to streamline and coordinate AI adoption. These results come from a survey of 260 large organizations that operate globally, conducted by leading technology industry market research firm Vanson Bourne on behalf of Teradata (NYSE: TDC), the leading data and analytics company.
“There is an important trend emerging evident in this report — enterprises today see AI as a strategic priority that will help them outpace the competition in their respective industries,” says Atif Kureishy, Vice President, Emerging Practices at Think Big Analytics, a Teradata company. “But to leverage the full potential of this technology and gain maximum ROI, these businesses will need to revamp their core strategies so AI has an embedded role from the data center to the boardroom.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8075951-teradata-state-of-artificial-intelligence-ai-for-enterprises/
